Grifols (GRFS) Enterprise Value (QoQ) (2011 - 2020)

Grifols (GRFS) Enterprise Value (QoQ) (2011 - 2020) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Grifols - - -

Historic Data

Download Data
DateValue
Dec 31, 2020 -40.18%
Mar 31, 2020 470.84%
Dec 31, 2019 -185.56%
Dec 31, 2018 -24,493.72%
Sep 30, 2018 -40.57%
Jun 30, 2018 -99.22%
Mar 31, 2018 155.65%
Dec 31, 2016 -21,441.58%
Sep 30, 2016 -3.81%
Dec 31, 2015 -24,355.44%
Sep 30, 2015 124,589.41%
Jun 30, 2015 -99.91%
Mar 31, 2015 100.35%
Dec 31, 2014 -18,489.45%
Sep 30, 2014 -11.42%
Jun 30, 2014 28.30%
Mar 31, 2014 100.67%
Dec 31, 2013 -50.00%
Sep 30, 2013 -3.64%
Jun 30, 2013 -15.91%